MYCN mediates cysteine addiction and sensitizes to ferroptosis
Alborzinia, H.; Florez, A. F.; Gogolin, S.; Brueckner, L. M.; Shao, C.; Gartlgruber, M.; Nadler Holly, M.; Ziehm, M.; Paul, F.; Steinhauser, S.; Bell, E.; Shaikhkarami, M.; Hartlieb, S.; Dreidax, D.; Hess, E. M.; Kreth, J.; Poschet, G.; Buettner, M.; Nicke, B.; Stresemann, C.; Reiling, J. H.; Fischer, M.; Amit, I.; Selbach, M.; Herrmann, C.; Woelfl, S.; Henrich, K. O.; Hoefer, T.; Westermann, F.
Show abstract
Aberrant expression of MYC family members predicts poor clinical outcome in many human cancers. Oncogenic MYC profoundly alters metabolism and mediates an antioxidant response to maintain redox balance. Here we show that MYC induces massive lipid peroxidation upon depletion of cysteine, the rate-limiting amino acid for glutathione biosynthesis and sensitizes cells to ferroptosis, an oxidative, non-apoptotic and irondependent type of cell death. In MYCN-amplified childhood neuroblastoma, MYCN mediates resistance to ferroptosis by activating transsulfuration of methionine to cysteine. MYCN may contribute to spontaneous tumor regression in low-risk neuroblastomas by promoting ferroptosis in cells with epigenetically silenced cystathionine-beta-synthase, the rate-limiting enzyme for transsulfuration. We identified enzymes and antiporter proteins crucial to ferroptotic escape, providing multiple previously unknown sites that may be acted on therapeutically.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade 98%
- ANP32E drives vulnerability to ATR inhibitors by inducing R-loops-dependent Transcription Replication Conflicts in Triple Negative Breast Cancer 98%
- Eukaryotic cell biology is temporally coordinated to support the energetic demands of protein homeostasis 98%
Similar papers in this journal
- Extracellular 2’3’-cGAMP is an immunotransmitter produced by cancer cells and regulated by ENPP1 98%
- Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response 97%
- The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1 97%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.